NCT01870336

Brief Summary

The purpose of this study is to evaluate the immediate and short-term effects of the combination of lateral customized foot orthoses on the pain and medial knee loading during gait among medial knee osteoarthritis patients. The effects of the combination is compared to the single use of these devices. The investigators recruited 22 knee osteoarthritis. They have to wear each of treatments (foot orthoses, knee brace and combination) during three months. A fifteen days wash-out period is given after each three months. Biomechanical evaluation is carried out before and after each three months. This evaluation consisted of three questionnaires (Knee Osteoarthritis Outcome Score (KOOS), Western Ontario and McMaster Universities Osteoarthritis Index ( WOMAC) and Medical Outcome Study Short Form-36( MOS-SF36)), a motion analysis with an optoelectronic system, then a 6-min walk test. During motion analysis, ten gait trials are executed without treatment and ten with the treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 6, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

March 4, 2016

Status Verified

March 1, 2016

Enrollment Period

1.7 years

First QC Date

May 23, 2013

Last Update Submit

March 3, 2016

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Knee adduction moment

    Change from Baseline at 3 months

  • Change in Knee pain

    A 20-cm visual analog scale (0-100) is used to assess pain.

    Change from Baseline at 3 months

Secondary Outcomes (3)

  • Change in Spatiotemporal gait parameters

    Change from Baseline at 3 months

  • Change in Knee adduction angle

    Change from Baseline at 3 months

  • Change in Comfort

    Change from Baseline at 3 months

Study Arms (3)

Lateral customized foot orthoses

EXPERIMENTAL

Foot orthoses with arch support and lateral inclination set at 7° (alone)

Device: Combined treatment of medial knee osteoarthritis

Knee brace

EXPERIMENTAL

OdrA Knee brace (alone)

Device: Combined treatment of medial knee osteoarthritis

Combination of the two treatments

EXPERIMENTAL

Combination of Lateral customized foot orthoses and knee brace

Device: Combined treatment of medial knee osteoarthritis

Interventions

Combination of the two treatmentsKnee braceLateral customized foot orthoses

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic medial knee OA (Kellgren-Lawrence grade I, II or III) according to clinical and radiological criteria of the American College of Rheumatology
  • Knee pain \> 31/100 (Western Ontario and McMaster Universities Arthritis Index - WOMAC)
  • Moderately active
  • Varus knee alignment equal or superior to 2°

You may not qualify if:

  • Severe knee OA (K-L grade IV)
  • Rheumatoid arthritis or other inflammatory arthritis
  • Avascular necrosis
  • History of periarticular fracture or septic arthritis
  • Bone metabolic disease
  • Pigmented villonodular synovitis
  • Cartilaginous disease
  • Neuropathic arthropathy
  • Synovial osteochondromatosis
  • Total or partial knee arthroplasty
  • Flexion contracture of ipsi- or contra-lateral knee greater than 15°
  • Hip or ankle joint damage with mobility limitation
  • Obesity (BMI ≥ 40)
  • Intra-articular corticosteroids injection in the affected knee during the two previous months
  • Reduced mobility (Charnley class C)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pavillon de l'Éducation Physique et des Sports - Université Laval

Québec, Quebec, G1V 0A6, Canada

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Philippe Corbeil, PhD

    Laval University

    STUDY DIRECTOR
  • Yoann Dessery, MSc

    Laval University

    PRINCIPAL INVESTIGATOR
  • Étienne L Belzile, MD

    Laval University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2013

First Posted

June 6, 2013

Study Start

September 1, 2012

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

March 4, 2016

Record last verified: 2016-03

Locations